Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
4Basebio Logo
4Basebio Growth Score
91
CB Rank
66861
Heat Score
76
4Basebio focuses on life science technology, DNA manufacturing, and supply DNA products to serve the fast-growing gene therapy market.
Founded
obfuscation
PublicPost-IPO Secondary Heidelberg, Baden-Wurttemberg, Germany11-50 www.4basebio.com/
Biotechnology
Health Care
Life Science
Therapeutics
Overview

4Basebio
Total Funding
obfuscation
Growth Score
91
Heat Score
76

Total Funding
obfuscation
obfuscation
Post-IPO Secondary raised
obfuscation
Growth Score91
-3 pts
in past quarter
Heat Score 76
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About 4Basebio

CB Rank
66861
4Basebio focuses on life science technology, DNA manufacturing, and supply DNA products to serve the fast-growing gene therapy market.
Founded
obfuscation
PublicPost-IPO Secondary Heidelberg, Baden-Wurttemberg, Germany11-50 www.4basebio.com/
Biotechnology
Health Care
Life Science
Therapeutics

Funding Rounds

Post-IPO Secondary
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

  • Photo of Scott Lorimer
    Scott Lorimer: Chief Operating Officer
    Past Role: Instil Bio, Vice President Technical Operations, Site Head
  • Photo of Heikki Lanckriet
    Heikki Lanckriet: Chief Executive Officer
    Past Role: Expedeon, CSO

Details

Legal Name 4basebio PLC
Operating Status Active
Stock Symbol  ETR:4BSB
Company Type For Profit
About the Company
4Basebio focuses on life science technology, DNA manufacturing, and supply DNA products to serve the fast-growing gene therapy market.
Phone Number 34 91 192 36 50
Predictions & Insights

Growth Insight

See this Growth Insight
4Basebio is
Lorem
 to be growing
Top Contributing Factors
Market Share Expansion

Products & Services

hpDNA
A double stranded linear DNA, with single strand hairpins at both ends, suitable for viral and non-viral vector applications.
osDNA
Incorporates nucleotide modifications for resistance to degradation and tuning immunostimulatory properties, ideal for DNA vaccine applications.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Secondary - 4Basebio Logo
Post-IPO Secondary - 4Basebio
2
obfuscation
Elevage Medical Technologies, M&G InvestmentsPost-IPO Secondary
obfuscation
Post-IPO Secondary - 4Basebio Logo
Post-IPO Secondary - 4Basebio
2
obfuscation
Elevage Medical Technologies, M&G InvestmentsPost-IPO Secondary
obfuscation
Post-IPO Secondary - 4Basebio Logo
Post-IPO Secondary - 4Basebio
2
obfuscation
Elevage Medical Technologies, M&G InvestmentsPost-IPO Secondary
obfuscation
Post-IPO Secondary - 4Basebio Logo
Post-IPO Secondary - 4Basebio
2
obfuscation
Elevage Medical Technologies, M&G InvestmentsPost-IPO Secondary
obfuscation
Post-IPO Secondary - 4Basebio Logo
Post-IPO Secondary - 4Basebio
2
obfuscation
Elevage Medical Technologies, M&G InvestmentsPost-IPO Secondary

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Secondary - 4Basebio Logo
Post-IPO Secondary - 4Basebio
2
obfuscation
Elevage Medical Technologies, M&G InvestmentsPost-IPO Secondary
obfuscation
Post-IPO Secondary - 4Basebio Logo
Post-IPO Secondary - 4Basebio
2
obfuscation
Elevage Medical Technologies, M&G InvestmentsPost-IPO Secondary
obfuscation
Post-IPO Secondary - 4Basebio Logo
Post-IPO Secondary - 4Basebio
2
obfuscation
Elevage Medical Technologies, M&G InvestmentsPost-IPO Secondary
obfuscation
Post-IPO Secondary - 4Basebio Logo
Post-IPO Secondary - 4Basebio
2
obfuscation
Elevage Medical Technologies, M&G InvestmentsPost-IPO Secondary
obfuscation
Post-IPO Secondary - 4Basebio Logo
Post-IPO Secondary - 4Basebio
2
obfuscation
Elevage Medical Technologies, M&G InvestmentsPost-IPO Secondary

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Contacts 34

Employee Profiles

News

News and Press

News•May 29, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

6,083
215.84%
 in past month

Active Website Tech Count

44Basebio is actively using 4 technologies for its website, according to BuiltWith. These include Euro, PHP, and  Sendgrid.
Sub-Organizations
Frequently Asked Questions

Where is 4Basebio's headquarters? 4Basebio is located in Heidelberg, Baden-Wurttemberg, Germany.Who invested in 4Basebio? 4Basebio has 4 investors including Elevage Medical Technologies and  M&G Investments.When was the last funding round for 4Basebio? 4Basebio closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has 4Basebio raised to date? 4Basebio has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8ea058e 1)
|